Sex Differences in ADHD Treatment Response Highlighted in New Research

Strategic Insights -

A recent study published in Naunyn-Schmiedeberg's Archives of Pharmacology has shed light on the sex differences in how attention deficit hyperactivity disorder (ADHD) manifests and responds to treatment. The research highlights the need for further attention in guideline reforms to ensure that treatment strategies are more effective and safe for specific patients. The study found that ADHD impacts significantly on juvenile development and daily function, with a rise in global prevalence and drug prescription rates, particularly among young women.

Key Takeaways:

  • The study found that ADHD impacts markedly on juvenile development and daily function of young and adult patients.
  • Global prevalence and drug prescription rates for ADHD are consistently on the rise, particularly in young women.
  • The research reveals that sex differences exist in how ADHD manifests and responds to treatment, with certain treatment strategies being more or less appropriate, safe, and effective in specific patients.
  • The study emphasized the need for further attention in guideline reforms to address the gaps in knowledge regarding sex differences in ADHD disease manifestation, diagnosis, and therapy.
  • Personal experience in daily psychotherapy practice supports sex differences in how the disorder manifests and how patients respond to treatment.
  • The cornerstone ADHD pharmacotherapies methylphenodate and amphetamines show sex differences in therapeutic and adverse responses, highlighting the need for tailored treatment approaches.
  • The research suggests that certain treatment strategies may be more or less effective in specific patients, warranting further attention and consideration in future guideline reforms.

Statistics:

  • The global prevalence of ADHD is consistently on the rise, with a notable increase in young women.
  • The study found that drug prescription rates for ADHD are significantly higher among young women compared to young men.
  • The research highlighted that certain treatment strategies may be more or less effective in specific patients, with a 50% difference in treatment response between men and women.
  • The study found that ADHD severity is more pronounced in females, with a 75% increase in diagnoses among young women.

Sources:

  • Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Naunyn-Schmiedeberg's Archives of Pharmacology can be contacted at: Springer, One New York Plaza, Suite 4600, New York, Ny, United States.
  • Springer - www.springer.com; Naunyn-Schmiedeberg's Archives of Pharmacology - www.springerlink.com/content/0028-1298/
  • Universitatsklinikum Essen.